Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$0.63 - $1.07 $11,946 - $20,289
-18,962 Reduced 41.39%
26,854 $18,000
Q1 2024

May 09, 2024

SELL
$0.82 - $1.35 $544 - $896
-664 Reduced 1.43%
45,816 $40,000
Q4 2023

Feb 07, 2024

BUY
$0.66 - $0.91 $15,386 - $21,214
23,313 Added 100.63%
46,480 $40,000
Q3 2023

Nov 08, 2023

BUY
$0.85 - $1.43 $7,140 - $12,013
8,401 Added 56.89%
23,167 $21,000
Q2 2023

Jul 28, 2023

BUY
$1.12 - $1.49 $16,537 - $22,001
14,766 New
14,766 $17,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $202M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.